English | Español

Astrazeneca Pharmaceuticals Lp
Mark Iandolo | Nov 22, 2017

AstraZeneca's benralizumab receives positive opinion from European Medicines Agency's CHMP
Mark Iandolo | Nov 22, 2017

AstraZeneca, MedImmune deliver 28 presentations at AHA Scientific Sessions
Nicholas Gueguen | Aug 1, 2017

MedImmune, Sanofi Pasteur to create and market respiratory tract illness prevention drug
Nicholas Gueguen | Jul 23, 2017

FDA approves AstraZeneca's Tagrisso for treating certain forms of lung cancer
Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments